Frank BELLIVIER
Biomarqueurs de la rechute & de la réponse au traitement dans les pathologies neuropsychiatriques
Unité de recherche : UMR_S1144
Université Paris Cité
Faculté des Sciences Pharmaceutiques et Biologiques
Optimisation thérapeutique en neuropsychopharmacologie
4 avenue de l’Observatoire
75270 Paris Cedex 06
Spécialité : Biochimie , Biologie cellulaire , Biologie moléculaire , Pharmacologie , Recherche clinique , Neurosciences
Directeur de l’unité de rattachement : Jean-Louis LAPLANCHE
__________________________________________________________________________________________________________________
Responsable de l’équipe de recherche
BELLIVIER Frank – MARIE-CLAIRE Cynthia
Courriel: frank.bellivier@inserm.fr
Courriel : cynthia.marie-claire@u-paris.fr
Tél: FB – 01 40 05 42 25
Tél : M-C.C- 01 53 73 99 90
__________________________________________________________________________________________________________________
Composition de l’équipe de recherche
- AMAR -BOUAZIZ Elodie (MCU-PH)
- BELLIVIER Frank (PUPH, HDR)
- BLOCH Vanessa (MCU-PH, HDR)
- COGNAT Emmanuel (MCU-PH)
- DEREUX Alexandra (PH)
- ETAIN Bruno (PU-PH, HDR)
- FARID Karim (PU-PH, HDR)
- ICICK Romain (PH-HDR)
- JACOB Aude (MCU-PH)
- LAPLANCHE Jean-Louis (PU-PH, HDR)
- MARIE-CLAIRE Cynthia (DR, HDR)
- MOUTON-LIGER François (MCF, HDR)
- PAQUET Claire (PU-PH, HDR)
- QUESTEL Franck (PH)
- VORSPAN Florence (PU-PH, HDR)
__________________________________________________________________________________________________________
5 publications récentes de l’équipe de recherche
Spano L, Etain B, Meyrel M et al. Telomere length and mitochondrial DNA copy number in bipolar disorder: identification of a subgroup of young individuals with accelerated cellular aging. Transl Psychiatry. 2022 Apr 1;12(1):135.
Marie-Claire C, Courtin C, Bellivier F et al. Methylomic Biomarkers of Lithium Response in Bipolar Disorder: A Proof of Transferability Study Pharmaceuticals (Basel). 2022 Oct 23;15(2): doi: 10.3390/ph15020133
Dumurgier J., Sabia S. Zetterberg H. al A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging. Neurology. 2022; 99(7): e669-e678. doi: 10.1212/WNL.0000000000200735.
Icick R, Bloch V, Prince N et al. Clustering suicidal phenotypes and genetic associations with brain-derived neurotrophic factor in patients with substance use disorders. Transl Psychiatry. 2021 Jan 21;11(1):72. doi: 10.1038/s41398-021-01200-5.
Clergue-Duval V, Vrillon A, Jeanblanc J et al. Plasma tau, NfL, GFAP and UCHL1 as candidate biomarkers of alcohol withdrawal- associated brain damage: A pilot study. Addict Biol. 2022 Nov;27(6):e13232.
Ashton NJ., Puig-Pijoan A., Aloma MM et al Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays Alzheimers Dement. 2023 9(5):1913-1924. doi: 10.1002/alz.12841